Anatomic Stage IIIA Breast Cancer AJCC v8 Withdrawn Phase 1 Trials for Lorcaserin (DB04871)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04205071Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerTreatment